Sildenafil citrate for female sexual arousal disorder: A future possibility?

Nature Reviews Urology

Volumn 6, Issue 4, 2009, Pages 216-222

  Schoen, Corina ^a   Bachmann, Gloria ^a  

^a ROBERT WOOD JOHNSON UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; PLACEBO; SILDENAFIL; CYCLIC NUCLEOTIDE PHOSPHODIESTERASE 2; PIPERAZINE DERIVATIVE; PURINE DERIVATIVE; SULFONE;

AMPLITUDE MODULATION; CLINICAL TRIAL; COITUS; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; FANTASY; FEMALE SEXUAL AROUSAL DISORDER; HOT FLUSH; HUMAN; MAJOR DEPRESSION; NAUSEA; ORGASM; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RHINITIS; SEXUAL AROUSAL DISORDER; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION; SEXUAL INTERCOURSE; SEXUAL SATISFACTION; THERAPY EFFECT; VAGINAL PULSE AMPLITUDE; VISUAL DISORDER; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; FEMALE; FORECASTING; LIBIDO; METHODOLOGY; PHYSIOLOGY; PSYCHOSEXUAL DISORDER; RANDOMIZED CONTROLLED TRIAL;

ANIMALS; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 2; FEMALE; FORECASTING; HUMANS; LIBIDO; PIPERAZINES; PURINES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; SULFONES;

EID: 70350232152     PISSN: 17594812     EISSN: 17594820     Source Type: Journal    
DOI: 10.1038/nrurol.2009.25     Document Type: Review

References (49)

1. Laumann, e. O., Paik, A. & rosen, r. C. sexual dysfunction in the United states: prevalence and predictors. JAMA 281, 537-544 (1999).
2. shifren, J. L., Monz, B. U., russo, P. A., segreti, A. & Johannes, C. B. sexual problems and distress in United states women: prevalence and correlates. Obstet. Gynecol. 112, 970-978 (2008).
3. west, s. L. et al. Prevalence of low sexual desire and hypoactive sexual desire disorder in a nationally representative sample of Us women. Arch. Intern. Med. 168, 1441-1449 (2008).
4. Moreira, e. D., Glasser, D. B., Nicolosi, A., Duarte, F. G. & Gingell, C. sexual problems and help-seeking behaviour in adults in the United Kingdom and continental europe. BJU Int. 101, 1005-1011 (2008).
5. world Health Organization (online 4 May 2006) international statistical Classification of Diseases and related Health Problems, 10th revision, version for 2007 [http://www.who. int/classifications/apps/icd/icd10online/] (accessed 10 February 2009).
6. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR, 4th edn (American Psychiatric Publishing, Arlington, 2000).
7. Masters, w. H. & Johnson, v. e. Human Sexual Response. Boston: Little, Brown and Company (1966).
8. Kaplan, H. s. Hypoactive sexual desire. J. Sex. Marital. Ther. 3, 3-9 (1977).
9. Basson, r. rethinking low sexual desire in women. BJOG 109, 357-363 (2002).
10. Basson, r. et al. revised definitions of women's sexual dysfunction. J. Sex. Med. 1, 40-48 (2004).
11. Hatzimouratidis, K. & Hatzichristou, D. sexual dysfunctions: classifications and definitions. J. Sex. Med. 4, 241-250 (2007).
12. Basson, r. women's sexual dysfunction: revised and expanded definitions. CMAJ 172, 1327-1333 (2005).
13. Laan, e. Genital responsiveness in healthy women with and without sexual arousal disorder. J. Sex. Med. 5, 1424-1435 (2008).
14. Gragasin, F. s. et al. The neurovascular mechanism of clitoral erection: nitric oxide and cGMP-stimulated activation of BKCa channels. FASEB J. 18, 1382-1391 (2004).
15. D'Amati, G. et al. Type 5 phosphodiesterase expression in the human vagina. Urology 60, 191-195 (2002).
16. Oelke, M. et al. expression of cAMP and cGMPphosphodiesterase isoenzymes 3, 4, and 5 in the human clitoris: immunohistochemical and molecular biology study. Urology 67, 1111-1116 (2006).
17. Uckert, s., ellinghaus, P., Albrecht, K., Jonas, U. & Oelke, M. expression of messenger ribonucleic acid encoding for phosphodiesterase isoenzymes in human female genital tissues. J. Sex. Med. 4, 1604-1609 (2007).
18. Goldstein, i. et al. Oral sildenafil in the treatment of erectile dysfunction. sildenafil study Group. N. Engl. J. Med. 338, 1397-1404 (1998).
19. Jones, L. A. et al. effect of sildenafil citrate on the male sexual experience assessed with the sexual experience Questionnaire: a multicenter, double-blind, placebo-controlled trial with openlabel extension. J. Sex. Med. 5, 1955-1964 (2008).
20. Derry, F. A. et al. efficacy and safety of oral sildenafil (viagra) in men with erectile dysfunction caused by spinal cord injury. Neurology 51, 1629-1633 (1998).
21. Maytom, M. C. et al. A two-part pilot study of sildenafil (viAGrA) in men with erectile dysfunction caused by spinal cord injury. Spinal Cord 37, 110-116 (1999).
22. Nurnberg, H. G. et al. Treatment of antidepressant-associated sexual dysfunction with sildenafil: a randomized controlled trial. JAMA 289, 56-64 (2003).
23. sipski, M. L., rosen, r. C., Alexander, C. J. & Hamer, r. M. sildenafil effects on sexual and cardiovascular responses in women with spinal cord injury. Urology 55, 812-815 (2000).
24. Berman, J. r., Berman, L. & Goldstein, i. Female sexual dysfunction: incidence, pathophysiology, evaluation, and treatment options. Urology 54, 385-391 (1999).
25. Caruso, s., intelisano, G., Lupo, L. & Agnello, C. Premenopausal women affected by sexual arousal disorder treated with sildenafil: a double-blind, cross-over, placebo-controlled study. BJOG 108, 623-628 (2001).
26. McCoy, N. L. & Matyas, J. r. Oral contraceptives and sexuality in university women. Arch. Sex. Behav. 25, 73-90 (1996).
27. Dennerstein, L., Dudley, e. C., Hopper, J. L. & Burger, H. sexuality, hormones and the menopausal transition. Maturitas 26, 83-93 (1997).
28. Laan, e. et al. The enhancement of vaginal vasocongestion by sildenafil in healthy premenopausal women. J. Womens Health Gend. Based Med. 11, 357-365 (2002).
29. Basson, r., Mcinnes, r., smith, M. D., Hodgson, G. & Koppiker, N. efficacy and safety of sildenafil citrate in women with sexual dysfunction associated with female sexual arousal disorder. J. Womens Health Gend. Based Med. 11, 367-377 (2002).
30. Fugl-Meyer, A. r., Lodnert, G., Branholm, i. B. & Fugl-Meyer, K. s. On life satisfaction in male erectile dysfunction. Int. J. Impot. Res. 9, 141-148 (1997).
31. Quirk, F. H. et al. Development of a sexual function questionnaire for clinical trials of female sexual dysfunction. J. Womens Health Gend. Based Med. 11, 277-289 (2002).
32. Caruso, s., intelisano, G., Farina, M., Di Mari, L. & Agnello, C. The function of sildenafil on female sexual pathways: a double-blind, crossover, placebo-controlled study. Eur. J. Obstet. Gynecol. Reprod. Biol. 110, 201-206 (2003).
33. Basson, r. & Brotto, L. A. sexual psychophysiology and effects of sildenafil citrate in oestrogenised women with acquired genital arousal disorder and impaired orgasm: a randomised controlled trial. BJOG 110, 1014-1024 (2003).
34. Heiman, J. r. & rowland, D. L. Affective and physiological sexual response patterns: the effects of instructions on sexually functional and dysfunctional men. J. Psychosom. Res. 27, 105-116 (1983).
35. Berman, J. r., Berman, L. A., Toler, s. M., Gill, J. & Haughie, s. safety and efficacy of sildenafil citrate for the treatment of female sexual arousal disorder: a double-blind, placebo controlled study. J. Urol. 170, 2333-2338 (2003).
36. Berman, L. A., Berman, J. r., werbin, T., Chabra, s. & Goldstein, i. The use of the Female intervention efficacy index (Fiei) as an immediate outcome measure of medical intervention to treat female sexual dysfunction. J. Sex. Marital Ther. 27, 427-433 (2001).
37. Dasgupta, r., wiseman, O. J., Kanabar, G., Fowler, C. J. & Mikol, D. D. efficacy of sildenafil in the treatment of female sexual dysfunction due to multiple sclerosis. J. Urol. 171, 1189-1193 (2004).
38. Basson, r. et al. report of the international consensus development conference on female sexual dysfunction: definitions and classifications. J. Urol. 163, 888-893 (2000).
39. Caruso, s. et al. sildenafil improves sexual functioning in premenopausal women with type 1 diabetes who are affected by sexual arousal disorder: a double-blind, crossover, placebo-controlled pilot study. Fertil. Steril. 85, 1496-1501 (2006).
40. Nurnberg, H. G. et al. sildenafil treatment of women with antidepressant-associated sexual dysfunction: a randomized controlled trial. JAMA 300, 395-404 (2008).
41. Guy, w. ECDEU assessment manual for psychopharmacology (DHEW publication). rockville: U. s. Dept. of Health, education, and welfare, Public Health service, Alcohol, Drug Abuse, and Mental Health Administration, National institute of Mental Health, Psychopharmacology research Branch, Division of extramural research Programs; rev. (1976).
42. McGahuey, C. A. et al. The Arizona sexual experience scale (AseX): reliability and validity. J. Sex. Marital Ther. 26, 25-40 (2000).
43. Nurnberg, H. G. et al. The sexual function inventory: a screening instrument for antidepressant-associated sexual dysfunction. Presented at the American Psychiatric Association Annual Meeting: 2001 May 7, New Orleans, LA (2001).
44. Fava, M., rankin, M. A., Alpert, J. e., Nierenberg, A. A. & worthington, J. J. An open trial of oral sildenafil in antidepressant-induced sexual dysfunction. Psychother. Psychosom. 67, 328-331 (1998).
45. Nurnberg, H. G., Hensley, P. L., Lauriello, J., Parker, L. M. & Keith, s. J. sildenafil for women patients with antidepressant-induced sexual dysfunction. Psychiatr. Serv. 50, 1076-1078 (1999).
46. Ashton, A. K. sildenafil treatment of paroxetineinduced anorgasmia in a woman. Am. J. Psychiatry 156, 800 (1999).
47. Berman, J. r. et al. effect of sildenafil on subjective and physiologic parameters of the female sexual response in women with sexual arousal disorder. J. Sex. Marital Ther. 27, 411-420 (2001).
48. Cavalcanti, A. L. et al. effect of sildenafil on clitoral blood flow and sexual response in postmenopausal women with orgasmic dysfunction. Int. J. Gynaecol. Obstet. 102, 115-119 (2008).
49. Minhas, s. & Cartledge, J. J. relaxation induced by omeprazole does not change in diabetic rabbit corpus cavernosum. BJU Int. 88, 305-306 (2001).